LabGenomics Co. Ltd (KQ:084650) — Market Cap & Net Worth
Market Cap & Net Worth: LabGenomics Co. Ltd (084650)
LabGenomics Co. Ltd (KQ:084650) has a market capitalization of $3.36 Million (₩4.96 Billion) as of August 4, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #29244 globally and #2089 in its home market, demonstrating a -16.62% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying LabGenomics Co. Ltd's stock price ₩547.00 by its total outstanding shares 9076740 (9.08 Million). See reinvestment intensity of LabGenomics Co. Ltd to understand how much of operating cash flow is reinvested back into capital assets.
LabGenomics Co. Ltd Market Cap History: 2015 to 2026
LabGenomics Co. Ltd's market capitalization history from 2015 to 2026. Data shows change from $13.98 Million to $3.36 Million (-12.93% CAGR).
Index Memberships
LabGenomics Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$202.56 Billion | 0.00% | #1148 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$202.56 Billion | 0.00% | #1148 of 1384 |
Weight: LabGenomics Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
LabGenomics Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how LabGenomics Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
LabGenomics Co. Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $13.98 Million | $23.59 Billion | $1.63 Billion | 0.00x | 0.01x |
| 2016 | $10.19 Million | $24.06 Billion | $723.51 Million | 0.00x | 0.01x |
| 2017 | $10.19 Million | $24.81 Billion | -$3.44 Billion | 0.00x | N/A |
| 2018 | $6.11 Million | $27.54 Billion | -$3.97 Billion | 0.00x | N/A |
| 2019 | $5.05 Million | $33.18 Billion | $962.42 Million | 0.00x | 0.01x |
| 2020 | $18.51 Million | $119.48 Billion | $42.77 Billion | 0.00x | 0.00x |
| 2021 | $24.79 Million | $202.41 Billion | $83.85 Billion | 0.00x | 0.00x |
| 2022 | $19.38 Million | $144.77 Billion | $48.40 Billion | 0.00x | 0.00x |
| 2023 | $23.71 Million | $71.08 Billion | -$4.67 Billion | 0.00x | N/A |
| 2024 | $15.32 Million | $85.90 Billion | -$23.80 Billion | 0.00x | N/A |
Competitor Companies of 084650 by Market Capitalization
Companies near LabGenomics Co. Ltd in the global market cap rankings as of August 4, 2026.
Key companies related to LabGenomics Co. Ltd by market ranking:
- Cannassure Therapeutics Ltd (TA:CSURE): Ranked #31173 globally with a market cap of $217.46K USD ( ILA81.11 Million ILA).
- Kumho Industrial Co Ltd (KO:002995): Ranked #29235 globally with a market cap of $3.38 Million USD ( ₩4.99 Billion KRW).
- Guard Therapeutics International AB (ST:GUARD): Ranked #29236 globally with a market cap of $3.38 Million USD ( Skr31.42 Million SEK).
- Empire Metals Limited (LSE:EEE): Ranked #29245 globally with a market cap of $3.36 Million USD ( GBX27.65 Billion GBX).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #31173 | Cannassure Therapeutics Ltd | TA:CSURE | $217.46K | ILA604.90 |
| #29235 | Kumho Industrial Co Ltd | KO:002995 | $3.38 Million | ₩17220.00 |
| #29236 | Guard Therapeutics International AB | ST:GUARD | $3.38 Million | Skr1.56 |
| #29245 | Empire Metals Limited | LSE:EEE | $3.36 Million | GBX38.90 |
LabGenomics Co. Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, LabGenomics Co. Ltd's market cap moved from $13.98 Million to $ 3.36 Million, with a yearly change of -12.93%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩3.36 Million | -69.80% |
| 2025 | ₩11.14 Million | -27.27% |
| 2024 | ₩15.32 Million | -35.41% |
| 2023 | ₩23.71 Million | +22.38% |
| 2022 | ₩19.38 Million | -21.83% |
| 2021 | ₩24.79 Million | +33.91% |
| 2020 | ₩18.51 Million | +266.28% |
| 2019 | ₩5.05 Million | -17.31% |
| 2018 | ₩6.11 Million | -40.00% |
| 2017 | ₩10.19 Million | 0.00% |
| 2016 | ₩10.19 Million | -27.15% |
| 2015 | ₩13.98 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of LabGenomics Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.36 Million USD |
| MoneyControl | $3.36 Million USD |
| MarketWatch | $3.36 Million USD |
| marketcap.company | $3.36 Million USD |
| Reuters | $3.36 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About LabGenomics Co. Ltd
LabGenomics Co., Ltd. engages in the research and development of biotechnology products in South Korea. It is also involved in the sale of diagnostic devices. The company was founded in 2002 and is based in Seongnam-si, South Korea.